Does epigenetic markers of HLA gene show association with coronary artery disease in Indian subjects?

Background DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant Cp...

Full description

Saved in:
Bibliographic Details
Published inMolecular biology reports Vol. 51; no. 1; p. 173
Main Authors Banerjee, Shyamashree, Paradkar, Minal U., Ponde, Chandrashekhar K., Rajani, Rajesh M., Pillai, Sudhir, Ashavaid, Tester F.
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.12.2024
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0301-4851
1573-4978
1573-4978
DOI10.1007/s11033-023-08974-5

Cover

Abstract Background DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD. Methods Blood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann–Whitney U; Kruskal–Wallis’ rank test and two-way ANOVA by MedCalc (v19.6). Results Methylation levels in HLA-DQA1 for cg10217052 was 78.5 (37–85) and 76.5 (24–84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00–39.00) and 10.5 (5.00–29.0); while in cg08269402 were 52 (16–65) and 42.5 (17–61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity. Conclusion The present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD.
AbstractList DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD.BACKGROUNDDNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD.Blood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann-Whitney U; Kruskal-Wallis' rank test and two-way ANOVA by MedCalc (v19.6).METHODSBlood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann-Whitney U; Kruskal-Wallis' rank test and two-way ANOVA by MedCalc (v19.6).Methylation levels in HLA-DQA1 for cg10217052 was 78.5 (37-85) and 76.5 (24-84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00-39.00) and 10.5 (5.00-29.0); while in cg08269402 were 52 (16-65) and 42.5 (17-61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity.RESULTSMethylation levels in HLA-DQA1 for cg10217052 was 78.5 (37-85) and 76.5 (24-84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00-39.00) and 10.5 (5.00-29.0); while in cg08269402 were 52 (16-65) and 42.5 (17-61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity.The present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD.CONCLUSIONThe present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD.
BackgroundDNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD.MethodsBlood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann–Whitney U; Kruskal–Wallis’ rank test and two-way ANOVA by MedCalc (v19.6).ResultsMethylation levels in HLA-DQA1 for cg10217052 was 78.5 (37–85) and 76.5 (24–84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00–39.00) and 10.5 (5.00–29.0); while in cg08269402 were 52 (16–65) and 42.5 (17–61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity.ConclusionThe present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD.
BACKGROUND: DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD. METHODS: Blood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann–Whitney U; Kruskal–Wallis’ rank test and two-way ANOVA by MedCalc (v19.6). RESULTS: Methylation levels in HLA-DQA1 for cg10217052 was 78.5 (37–85) and 76.5 (24–84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00–39.00) and 10.5 (5.00–29.0); while in cg08269402 were 52 (16–65) and 42.5 (17–61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity. CONCLUSION: The present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD.
Background DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD. Methods Blood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann–Whitney U; Kruskal–Wallis’ rank test and two-way ANOVA by MedCalc (v19.6). Results Methylation levels in HLA-DQA1 for cg10217052 was 78.5 (37–85) and 76.5 (24–84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00–39.00) and 10.5 (5.00–29.0); while in cg08269402 were 52 (16–65) and 42.5 (17–61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity. Conclusion The present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD.
DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD. Blood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann-Whitney U; Kruskal-Wallis' rank test and two-way ANOVA by MedCalc (v19.6). Methylation levels in HLA-DQA1 for cg10217052 was 78.5 (37-85) and 76.5 (24-84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00-39.00) and 10.5 (5.00-29.0); while in cg08269402 were 52 (16-65) and 42.5 (17-61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity. The present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD.
ArticleNumber 173
Author Pillai, Sudhir
Ponde, Chandrashekhar K.
Rajani, Rajesh M.
Paradkar, Minal U.
Banerjee, Shyamashree
Ashavaid, Tester F.
Author_xml – sequence: 1
  givenname: Shyamashree
  surname: Banerjee
  fullname: Banerjee, Shyamashree
  organization: Research Laboratories, P.D Hinduja Hospital & Medical Research Centre
– sequence: 2
  givenname: Minal U.
  surname: Paradkar
  fullname: Paradkar, Minal U.
  organization: Research Laboratories, P.D Hinduja Hospital & Medical Research Centre, Department of Biochemistry, P.D Hinduja Hospital & Medical Research Centre
– sequence: 3
  givenname: Chandrashekhar K.
  surname: Ponde
  fullname: Ponde, Chandrashekhar K.
  organization: Department of Cardiology, P.D Hinduja Hospital & Medical Research Centre
– sequence: 4
  givenname: Rajesh M.
  surname: Rajani
  fullname: Rajani, Rajesh M.
  organization: Department of Cardiology, P.D Hinduja Hospital & Medical Research Centre
– sequence: 5
  givenname: Sudhir
  surname: Pillai
  fullname: Pillai, Sudhir
  organization: Department of Cardiology, P.D Hinduja Hospital & Medical Research Centre
– sequence: 6
  givenname: Tester F.
  surname: Ashavaid
  fullname: Ashavaid, Tester F.
  email: dr_tashavaid@hindujahospital.com, tashavaid@gmail.com
  organization: Research Laboratories, P.D Hinduja Hospital & Medical Research Centre, Department of Biochemistry, P.D Hinduja Hospital & Medical Research Centre
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38252175$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1vEzEQhi1URNPAH-CALHHhsuDPXfuEqkI_pEhc4Gx5vbOtQ2IHz66q_nucpIDUQzlYY42ed-x53zNyknICQt5y9pEz1n1CzpmUDRP1GNupRr8gC6472SjbmROyYJLxRhnNT8kZ4poxpninX5FTaYQW9bog8CUDUtjFW0gwxUC3vvyEgjSP9Hp1Tvdtinf5nnrEHKKfYk70Pk53NOSSky8P1JcJahkigkegMdGbNESfKM79GsKEn1-Tl6PfILx5rEvy4_Lr94vrZvXt6ubifNUExczUgDRj4H0YWzu0bT8KpfrW-rZlbdAGuOyF7rlnKljTW_AqSKk6pm0YVDcKIZfkw3HuruRfM-DkthEDbDY-QZ7RSa5lu3fB_BcVtvqjBat2Lsn7J-g6zyXVRQ5UnaaNrdS7R2rutzC4XYnVywf3x-sKiCMQSkYsMP5FOHP7QN0xUFcDdYdA3V5knohCnA4hTMXHzfNSeZRifSfdQvn37WdUvwEi4bMk
CitedBy_id crossref_primary_10_1016_j_aca_2024_343540
Cites_doi 10.1038/nature05919
10.1161/CIRCRESAHA.111.261388
10.2217/epi.12.62
10.1093/nar/16.3.1215
10.1194/jlr.M048504
10.1016/S0140-6736(12)60312-2
10.3389/fphar.2022.815977
10.1016/j.atherosclerosis.2018.07.014
10.1016/j.humimm.2011.11.003
10.4161/15592294.2014.970060
10.1038/ng1544
10.1186/s12920-015-0085-1
10.1042/BST20200602
10.1016/j.atherosclerosis.2004.04.027
10.1016/j.gheart.2012.10.003
10.1093/jn/132.8.2329s
10.1007/s11033-018-4507-y
10.1038/onc.2011.354
10.1016/S0021-9150(97)00101-9
10.1016/j.xcrm.2022.100805
10.1186/1868-7083-6-14
10.1097/MOL.0000000000000059
10.1007/s10654-014-9984-2
10.2217/epi.10.32
10.1016/j.ygeno.2023.110565
10.1002/0471142727.mb0709s91.Bisulfite
10.1038/nature05913
10.1016/j.tcm.2017.12.012
10.1089/dna.2007.0694
10.4161/epi.27981
10.3389/fgene.2020.00171
10.1007/s11033-020-05723-w
10.1371/journal.pone.0009692
10.1371/journal.pone.0102265
10.1186/s13073-020-00778-7
10.1016/j.atherosclerosis.2021.03.043
10.1016/j.gene.2014.02.034
10.1016/j.humimm.2017.06.003
10.1161/CIRCRESAHA.116.310324
10.1186/s13148-017-0353-3
10.1136/heartasia
10.1016/j.arr.2009.03.004
10.3892/ijmm.2018.3453
10.1038/nrg3230
10.1083/jcb.201412052
10.1016/j.gene.2019.144107
10.1056/NEJM199901143400207
10.1161/CIRCULATIONAHA.118.039357
10.1136/annrheumdis-2014-206998
10.1016/j.mam.2012.08.001
10.1016/0002-9149(94)90918-0
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Nature B.V. 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2024. The Author(s), under exclusive licence to Springer Nature B.V.
Copyright Springer Nature B.V. Dec 2024
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Nature B.V. 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2024. The Author(s), under exclusive licence to Springer Nature B.V.
– notice: Copyright Springer Nature B.V. Dec 2024
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7TM
8FD
FR3
K9.
P64
RC3
7X8
7S9
L.6
DOI 10.1007/s11033-023-08974-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
Nucleic Acids Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Technology Research Database
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic
Genetics Abstracts
AGRICOLA

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1573-4978
EndPage 173
ExternalDocumentID 38252175
10_1007_s11033_023_08974_5
Genre Journal Article
GrantInformation_xml – fundername: Indian Council of Medical Research
  grantid: ICMR 2017-2844
  funderid: http://dx.doi.org/10.13039/501100001411
– fundername: Indian Council of Medical Research
  grantid: ICMR 2017-2844
GroupedDBID ---
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
123
1SB
203
28-
29M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3SX
4.4
406
408
409
40E
53G
5QI
5RE
5VS
67N
67Z
6NX
78A
7X7
88E
88I
8AO
8FE
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHBH
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABRTQ
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACGOD
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSTC
ACZOJ
ADBBV
ADHHG
ADHIR
ADHKG
ADIMF
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFEXP
AFGCZ
AFHIU
AFKRA
AFLOW
AFOHR
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHMBA
AHPBZ
AHSBF
AHWEU
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
ATHPR
AVWKF
AXYYD
AYFIA
AZFZN
AZQEC
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ7
GQ8
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAK
LK8
LLZTM
M1P
M2P
M4Y
M7P
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
PF0
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
TUS
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WJK
WK6
WK8
YLTOR
Z45
ZMTXR
ZOVNA
ZXP
~A9
~EX
~KM
AAYXX
CITATION
PUEGO
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7TM
8FD
FR3
K9.
P64
RC3
7X8
7S9
L.6
ID FETCH-LOGICAL-c408t-e38fc1bcf69d66bf244b69a6606c58e13b25b1a04c98b9ea4c3347059cd47f223
IEDL.DBID AGYKE
ISSN 0301-4851
1573-4978
IngestDate Fri Aug 22 20:36:49 EDT 2025
Wed Oct 01 13:34:45 EDT 2025
Tue Oct 07 05:52:07 EDT 2025
Mon Jul 21 05:55:24 EDT 2025
Thu Apr 24 23:07:25 EDT 2025
Wed Oct 01 03:58:50 EDT 2025
Mon Jul 21 06:06:48 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords gene
Pyrosequencing
Epigenetics
DNA methylation
Epigenome-wide association study
Human leucocyte antigen
Coronary artery disease
Human leucocyte antigen (HLA) gene
Language English
License 2024. The Author(s), under exclusive licence to Springer Nature B.V.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c408t-e38fc1bcf69d66bf244b69a6606c58e13b25b1a04c98b9ea4c3347059cd47f223
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 38252175
PQID 2917418589
PQPubID 54080
PageCount 1
ParticipantIDs proquest_miscellaneous_3153600418
proquest_miscellaneous_2917552057
proquest_journals_2917418589
pubmed_primary_38252175
crossref_primary_10_1007_s11033_023_08974_5
crossref_citationtrail_10_1007_s11033_023_08974_5
springer_journals_10_1007_s11033_023_08974_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-12-01
PublicationDateYYYYMMDD 2024-12-01
PublicationDate_xml – month: 12
  year: 2024
  text: 2024-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
– name: Netherlands
PublicationSubtitle An International Journal on Molecular and Cellular Biology
PublicationTitle Molecular biology reports
PublicationTitleAbbrev Mol Biol Rep
PublicationTitleAlternate Mol Biol Rep
PublicationYear 2024
Publisher Springer Netherlands
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
References A Stanley (8974_CR31) 2017; 9
Y Xiong (8974_CR38) 2017; 78
JC Wang (8974_CR41) 2012; 111
M Swanberg (8974_CR34) 2005; 37
AP Feinberg (8974_CR6) 2007; 447
B Liu (8974_CR10) 2012; 73
SA Miller (8974_CR23) 1988; 16
V Calvanese (8974_CR43) 2009; 8
HU Khan (8974_CR53) 2014; 26
C Miceli-Richard (8974_CR47) 2016; 75
A Bird (8974_CR5) 2007; 447
T Mikeska (8974_CR40) 2010; 2
Y Salameh (8974_CR44) 2020
PA Jones (8974_CR7) 2012; 13
P Lopez-Serra (8974_CR8) 2012; 31
ML Lévesque (8974_CR22) 2014
S-P Guay (8974_CR18) 2012; 4
Y Dai (8974_CR12) 2022
B Indumathi (8974_CR52) 2020; 47
RP Darst (8974_CR24) 2010
S Zaina (8974_CR11) 2014; 25
P Peng (8974_CR29) 2014; 9
S Ghose (8974_CR4) 2019; 721
SP Guay (8974_CR35) 2014; 9
AC Frazier-Wood (8974_CR28) 2014; 55
I Tabas (8974_CR45) 2015; 209
M Nakatochi (8974_CR15) 2017; 9
P Raggi (8974_CR33) 2018; 276
L Duan (8974_CR2) 2018; 28
T Muka (8974_CR26) 2015; 30
S Udali (8974_CR3) 2013; 34
CA Castellani (8974_CR46) 2020
C Limas (8974_CR37) 1994; 74
P Sharma (8974_CR19) 2008; 27
MH Forouzanfar (8974_CR1) 2012; 7
MP Valencia-Morales (8974_CR9) 2015; 8
M Kim (8974_CR32) 2010
SA Ross (8974_CR42) 2002; 132
L Jonasson (8974_CR39) 1997; 133
S Banerjee (8974_CR21) 2019; 46
GK Hansson (8974_CR36) 1986; 64
R Ross (8974_CR27) 1999; 340
J Kain (8974_CR48) 2022
A Yilmaz (8974_CR13) 2004; 176
BF Voight (8974_CR30) 2012; 380
Y Yamada (8974_CR16) 2018
R Methorst (8974_CR50) 2021; 325
G Agha (8974_CR51) 2019; 140
X Yuan (8974_CR49) 2023
S-P Guay (8974_CR25) 2014; 6
K Ley (8974_CR14) 2020; 48
J Li (8974_CR17) 2017; 120
P Sharma (8974_CR20) 2014; 541
References_xml – volume: 447
  start-page: 433
  issue: 7143
  year: 2007
  ident: 8974_CR6
  publication-title: Nature
  doi: 10.1038/nature05919
– volume: 111
  start-page: 245
  issue: 2
  year: 2012
  ident: 8974_CR41
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.111.261388
– volume: 4
  start-page: 623
  issue: 6
  year: 2012
  ident: 8974_CR18
  publication-title: Epigenomics
  doi: 10.2217/epi.12.62
– volume: 16
  start-page: 1215
  issue: 3
  year: 1988
  ident: 8974_CR23
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/16.3.1215
– volume: 55
  start-page: 1324
  issue: 7
  year: 2014
  ident: 8974_CR28
  publication-title: J Lipid Res
  doi: 10.1194/jlr.M048504
– volume: 380
  start-page: 572
  issue: 9841
  year: 2012
  ident: 8974_CR30
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(12)60312-2
– year: 2022
  ident: 8974_CR12
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2022.815977
– volume: 276
  start-page: 98
  year: 2018
  ident: 8974_CR33
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2018.07.014
– volume: 73
  start-page: 122
  issue: 1
  year: 2012
  ident: 8974_CR10
  publication-title: Hum Immunol
  doi: 10.1016/j.humimm.2011.11.003
– year: 2014
  ident: 8974_CR22
  publication-title: Epigenetics
  doi: 10.4161/15592294.2014.970060
– volume: 26
  start-page: 466
  issue: 4
  year: 2014
  ident: 8974_CR53
  publication-title: J Ayub Med Coll
– volume: 37
  start-page: 486
  issue: 5
  year: 2005
  ident: 8974_CR34
  publication-title: Nat Genet
  doi: 10.1038/ng1544
– volume: 8
  start-page: 7
  issue: 1
  year: 2015
  ident: 8974_CR9
  publication-title: BMC Med Genomics
  doi: 10.1186/s12920-015-0085-1
– volume: 48
  start-page: 2273
  issue: 5
  year: 2020
  ident: 8974_CR14
  publication-title: Biochem Soc Trans
  doi: 10.1042/BST20200602
– volume: 176
  start-page: 101
  issue: 1
  year: 2004
  ident: 8974_CR13
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2004.04.027
– volume: 7
  start-page: 331
  issue: 4
  year: 2012
  ident: 8974_CR1
  publication-title: Glob Heart
  doi: 10.1016/j.gheart.2012.10.003
– volume: 132
  start-page: 2406
  issue: 8 SUPPL.
  year: 2002
  ident: 8974_CR42
  publication-title: J Nutr
  doi: 10.1093/jn/132.8.2329s
– volume: 46
  start-page: 541
  issue: 1
  year: 2019
  ident: 8974_CR21
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-018-4507-y
– volume: 64
  start-page: 261
  issue: 2
  year: 1986
  ident: 8974_CR36
  publication-title: Clin Exp Immunol
– volume: 31
  start-page: 1609
  issue: 13
  year: 2012
  ident: 8974_CR8
  publication-title: Oncogene
  doi: 10.1038/onc.2011.354
– volume: 133
  start-page: 111
  year: 1997
  ident: 8974_CR39
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(97)00101-9
– year: 2022
  ident: 8974_CR48
  publication-title: Cell Rep Med
  doi: 10.1016/j.xcrm.2022.100805
– volume: 6
  start-page: 14
  year: 2014
  ident: 8974_CR25
  publication-title: Clin Epigenetics
  doi: 10.1186/1868-7083-6-14
– volume: 25
  start-page: 148
  issue: 2
  year: 2014
  ident: 8974_CR11
  publication-title: Curr Opin Lipidol
  doi: 10.1097/MOL.0000000000000059
– volume: 30
  start-page: 251
  issue: 4
  year: 2015
  ident: 8974_CR26
  publication-title: Eur J Epidemiol
  doi: 10.1007/s10654-014-9984-2
– volume: 2
  start-page: 561
  issue: 4
  year: 2010
  ident: 8974_CR40
  publication-title: Epigenomics
  doi: 10.2217/epi.10.32
– year: 2023
  ident: 8974_CR49
  publication-title: Genomics
  doi: 10.1016/j.ygeno.2023.110565
– year: 2010
  ident: 8974_CR24
  publication-title: Curr Protoc Mol Biol
  doi: 10.1002/0471142727.mb0709s91.Bisulfite
– volume: 447
  start-page: 396
  issue: 7143
  year: 2007
  ident: 8974_CR5
  publication-title: Nature
  doi: 10.1038/nature05913
– volume: 28
  start-page: 311
  issue: 5
  year: 2018
  ident: 8974_CR2
  publication-title: Trends Cardiovasc Med
  doi: 10.1016/j.tcm.2017.12.012
– volume: 27
  start-page: 357
  issue: 7
  year: 2008
  ident: 8974_CR19
  publication-title: DNA Cell Biol
  doi: 10.1089/dna.2007.0694
– volume: 9
  start-page: 718
  issue: 5
  year: 2014
  ident: 8974_CR35
  publication-title: Epigenetics
  doi: 10.4161/epi.27981
– year: 2020
  ident: 8974_CR44
  publication-title: Front Genet
  doi: 10.3389/fgene.2020.00171
– volume: 47
  start-page: 6693
  issue: 9
  year: 2020
  ident: 8974_CR52
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-020-05723-w
– year: 2010
  ident: 8974_CR32
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0009692
– volume: 9
  start-page: 8
  issue: 8
  year: 2014
  ident: 8974_CR29
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0102265
– year: 2020
  ident: 8974_CR46
  publication-title: Genome Med
  doi: 10.1186/s13073-020-00778-7
– volume: 325
  start-page: 30
  year: 2021
  ident: 8974_CR50
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2021.03.043
– volume: 541
  start-page: 31
  issue: 1
  year: 2014
  ident: 8974_CR20
  publication-title: Gene
  doi: 10.1016/j.gene.2014.02.034
– volume: 78
  start-page: 540
  issue: 9
  year: 2017
  ident: 8974_CR38
  publication-title: Hum Immunol
  doi: 10.1016/j.humimm.2017.06.003
– volume: 120
  start-page: 1754
  issue: 11
  year: 2017
  ident: 8974_CR17
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.116.310324
– volume: 9
  start-page: 1
  issue: 1
  year: 2017
  ident: 8974_CR15
  publication-title: Clin Epigenet
  doi: 10.1186/s13148-017-0353-3
– volume: 9
  start-page: 1
  year: 2017
  ident: 8974_CR31
  publication-title: Heart Asia
  doi: 10.1136/heartasia
– volume: 8
  start-page: 268
  issue: 4
  year: 2009
  ident: 8974_CR43
  publication-title: Ageing Res Rev
  doi: 10.1016/j.arr.2009.03.004
– year: 2018
  ident: 8974_CR16
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2018.3453
– volume: 13
  start-page: 484
  issue: 7
  year: 2012
  ident: 8974_CR7
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg3230
– volume: 209
  start-page: 13
  issue: 1
  year: 2015
  ident: 8974_CR45
  publication-title: J Cell Biol
  doi: 10.1083/jcb.201412052
– volume: 721
  start-page: 144107
  issue: 201
  year: 2019
  ident: 8974_CR4
  publication-title: Gene
  doi: 10.1016/j.gene.2019.144107
– volume: 340
  start-page: 115
  issue: 2
  year: 1999
  ident: 8974_CR27
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199901143400207
– volume: 140
  start-page: 645
  issue: 8
  year: 2019
  ident: 8974_CR51
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.118.039357
– volume: 75
  start-page: 933
  issue: 5
  year: 2016
  ident: 8974_CR47
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2014-206998
– volume: 34
  start-page: 883
  issue: 4
  year: 2013
  ident: 8974_CR3
  publication-title: Mol Aspects Med
  doi: 10.1016/j.mam.2012.08.001
– volume: 74
  start-page: 510
  issue: 5
  year: 1994
  ident: 8974_CR37
  publication-title: Am J Cardiol
  doi: 10.1016/0002-9149(94)90918-0
SSID ssj0004175
Score 2.3875525
Snippet Background DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery...
DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD)....
BackgroundDNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery...
BACKGROUND: DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 173
SubjectTerms Animal Anatomy
Animal Biochemistry
Biomedical and Life Sciences
blood
Cardiovascular disease
Coronary artery disease
Coronary Artery Disease - genetics
Coronary vessels
CpG islands
DNA methylation
DNA Methylation - genetics
DNA microarrays
DQA1 protein
Drb1 protein
Epigenesis, Genetic - genetics
Epigenetics
genes
Heart diseases
high-throughput nucleotide sequencing
Histocompatibility antigen HLA
Histology
Humans
Life Sciences
lipid composition
Lipids
Male
males
microarray technology
Morphology
Original Article
Vascular Diseases
Vein & artery diseases
Title Does epigenetic markers of HLA gene show association with coronary artery disease in Indian subjects?
URI https://link.springer.com/article/10.1007/s11033-023-08974-5
https://www.ncbi.nlm.nih.gov/pubmed/38252175
https://www.proquest.com/docview/2917418589
https://www.proquest.com/docview/2917552057
https://www.proquest.com/docview/3153600418
Volume 51
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1573-4978
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0004175
  issn: 0301-4851
  databaseCode: AFBBN
  dateStart: 19970301
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1573-4978
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0004175
  issn: 0301-4851
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1573-4978
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004175
  issn: 0301-4851
  databaseCode: U2A
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dT9RAEJ_AESMviqh4CmRNfNMl7X7048lcEDjE-OQl-NTsZzRqS653Medf72w_rkGEhNd220xnZzu_3Zn5DcAbl1jp8tRRxbingllDNWeW6jRyPpO5t7ZJkP2cTGfi46W87IrC6j7bvQ9JNn_qodgtDn3H0MfQKEMUTOUmbDV8WyPYmpx9vTgZ6iHjhmA3oH0qEFJ0xTL_f8t1h3QDZd6IkDaO5_QxzHqR23yTH0fLhT4yf_5hc7zvN-3Aow6JkklrOk9gw5W78KDtTbnahYfHfSu4p-A-VK4m7iowd4aiR_IrJPXMa1J5Mv00IeEyqb9Vv4kaZpuEI15iAkOCmq9Ikzu6Il1AiHwvyXkZbJPUSx3Ogur3z2B2evLleEq7_gzUiChbUMczb2JtfJLbJNEekYJOcpXgnsjIzMVcM6ljFQmTZzp3ShjORYp4zliResQlz2FUVqV7AcSn-Ju1wgijPAK4XEtmIh8rBHvK8siPIe4nqTAdeXnoofGzGGiXgyoLVGXRqLKQY3i7fuaqpe64c_R-P_dFt4zrguFmNrD7ZPkYXq9vo_JDVEWVrlq2Y6RkiHtvH8PRryTBLrMx7LV2tRaJ4x4d94UowLveRgYBbpf35f2Gv4JthnCsTcTZh9FivnQHCKcW-rBbPYewOWOTv6fIFPg
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Li9RAEC50RdaL6PoaXbUFb9qQ9COPkwyry6yOe9qBvYV-oqDJMplB5t9blccEWVfwmnRCkap0fdVV9RXA25B5Hco8cCNk5Ep4x60Unts8CbHQZfS-K5A9zxYr9flSXw5NYe1Y7T6mJLudemp2S2nuGPoYnhSIgrm-DXeIwIoY81diPnVDph29LmF9rhBQDK0yf3_Hn-7oGsa8lh_t3M7pA7g_4EU27xX8EG6F-gju9hMkd0dweDIObHsE4WMTWhauiF-TWhPZTyq9WbesiWyxnDO6zNpvzS9mJp0wOohljngMzHrHugrPHRvSNux7zc5qsiDWbi2d2LQfHsPq9NPFyYIPUxS4U0mx4UEW0aXWxaz0WWYj-nOblSbDyMXpIqTSCm1TkyhXFrYMRjkpVY6oy3mVR0QPT-CgburwDFjMcTP0yilnIsKs0mrhkpgahGTGyyTOIB0_ZuUGinGadPGjmsiRSQEVKqDqFFDpGbzbP3PVE2z8c_XxqKNq-NnaSmDISRw8RTmDN_vb-PEp92Hq0Gz7NVoLRKc3r5G4-2dkP8UMnvb634skMZLG6A0FeD8axCTAzfI-_7_lr-FwcfF1WS3Pzr-8gHsCAVRfOnMMB5v1NrxEALSxrzp7_w0Zp_np
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB5BEZQLKoWWQFsWiRusau_DjxOKWqL0oYoDkXqz9qlWAjuKE6H8e2b9iItKkbjaa2u0M_Z8szPzDcBHl1jp8tRRxbingllDNWeW6jRyPpO5t7YpkL1KpjNxfi2v73TxN9XufUqy7WkILE3l8nhu_fHQ-BaHGWTob2iUISKm8jE8EYEoAS16xsZDZ2TcUO0G3E8Fgouubebv7_jTNd3Dm_dypY0LmuzAiw47knGr7JfwyJW78LSdJrnehe2TfnjbK3CnlauJmweuzdCmSH6GMpxFTSpPppdjEi6T-qb6RdSgHxIOZYkJnAZqsSZNteeadCkccluSszJYE6lXOpze1F9ew2zy9fvJlHYTFagRUbakjmfexNr4JLdJoj36dp3kKsEoxsjMxVwzqWMVCZNnOndKGM5FigjMWJF6RBJ7sFVWpXsDxKf4Y7TCCKM8Qq5cS2YiHyuEZ8ryyI8g7jezMB3deJh68aMYiJKDAgpUQNEooJAj-LR5Zt6Sbfxz9UGvo6L78OqCYfgZ-HiyfAQfNrdx80MeRJWuWrVrpGSIVB9ew9ETJMF-shHst_rfiMQxqsZIDgX43BvEIMDD8r79v-Xv4dm300lxeXZ18Q6eM8RSbRXNAWwtFyt3iFhoqY8ac_8NhNf-JQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Does+epigenetic+markers+of+HLA+gene+show+association+with+coronary+artery+disease+in+Indian+subjects%3F&rft.jtitle=Molecular+biology+reports&rft.au=Banerjee%2C+Shyamashree&rft.au=Paradkar%2C+Minal+U.&rft.au=Ponde%2C+Chandrashekhar+K.&rft.au=Rajani%2C+Rajesh+M.&rft.date=2024-12-01&rft.issn=0301-4851&rft.eissn=1573-4978&rft.volume=51&rft.issue=1&rft_id=info:doi/10.1007%2Fs11033-023-08974-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11033_023_08974_5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0301-4851&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0301-4851&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0301-4851&client=summon